- $45.66m
- $50.47m
- $80.28m
Annual balance sheet for TELA Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 43.9 | 42 | 46.7 | 52.7 | 50.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.23 | 6.62 | 9.74 | 10.1 | 10.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 59.1 | 62.4 | 71.7 | 78.1 | 75.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.19 | 2.91 | 3.94 | 4.08 | 3.73 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 62.5 | 67.9 | 78 | 86.6 | 81.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.6 | 12.4 | 17 | 15.6 | 18 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 42.4 | 53.5 | 59.2 | 58.1 | 75.1 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 20.1 | 14.3 | 18.9 | 28.5 | 6.31 |
| Total Liabilities & Shareholders' Equity | 62.5 | 67.9 | 78 | 86.6 | 81.4 |
| Total Common Shares Outstanding |